首页> 外文期刊>Medicine. >Impact of Traditional Hospital Strain of Methicillin-Resistant Staphylococcus aureus (MRSA) and Community Strain of MRSA on Mortality in Patients With Community-Onset S aureus Bacteremia
【24h】

Impact of Traditional Hospital Strain of Methicillin-Resistant Staphylococcus aureus (MRSA) and Community Strain of MRSA on Mortality in Patients With Community-Onset S aureus Bacteremia

机译:传统医院耐甲氧西林金黄色葡萄球菌(MRSA)菌株和MRSA社区菌株对社区发病的金黄色葡萄球菌病患者死亡率的影响

获取原文
           

摘要

Community-associated methicillin-resistant Staphylococcus aureus (MRSA) has become an important pathogen in community and nosocomial infections. The impact of these emerging MRSA strains on mortality in adult patients with community-onset S aureus bacteremia remains uncertain. We defined community strain MRSA (CoSt-MRSA) and hospital strain MRSA (HoSt-MRSA) according to the results of staphylococcus cassette chromosome mec (SCCmec) molecular typing: CoSt-MRSA isolates had SCCmec type IV or V genes, and HoSt-MRSA isolates had SCCmec type I, II, or III genes. We quantitatively evaluated the impact of the MRSA strain on mortality in patients with CoSt-MRSA or HoSt-MRSA bacteremia by comparison with mortality in patients with methicillin-susceptible S aureus (MSSA) bacteremia. We studied an observational cohort of 500 patients with MSSA bacteremia, 111 patients with CoSt-MRSA, and 133 patients with HoSt-MRSA bacteremia from January 1, 2001, through December 31, 2007. The 90-day cumulative probability of survival in patients with MSSA, CoSt-MRSA, and HoSt-MRSA bacteremia was 71%, 70%, and 55%, respectively (p = 0.014, by Wilcoxon rank-sum test). Compared to patients with MSSA bacteremia, patients with HoSt-MRSA bacteremia were associated with an increased risk of mortality in the first multivariate analysis model adjusting for all potential confounders (hazard ratio [HR], 1.525; 95% confidence interval [CI], 1.091-2.131), in the second model adjusting for all confounders except acute severity of bacteremia (HR, 1.489; 95% CI, 1.071-2.070), and in stratified analysis in patients with low Charlson comorbidity scores (score 0-2) (HR, 3.093; 95% CI, 1.507-6.350). Compared to patients with MSSA bacteremia, patients with CoSt-MRSA bacteremia did not show significant differences in mortality rate in the 2 multivariate analysis models (first model: HR, 1.106; 95% CI, 0.748-1.637; second model: HR, 1.028; 95% CI, 0.697-1.516) or in stratified analysis (HR, 1.092; 95% CI, 0.539-2.214). In conclusion, using MSSA as reference, traditional hospital strain MRSA had a higher impact on bacteremia mortality than community strain MRSA. Abbreviations: CA-MRSA = community-associated methicillin-resistant Staphylococcus aureus, CI = confidence interval, CoSt-MRSA = community strain of methicillin-resistant Staphylococcus aureus, ED = emergency department, HoSt-MRSA = hospital strain of methicillin-resistant Staphylococcus aureus, HR = hazard ratio, MLST = multilocus sequence typing, MRSA = methicillin-resistant Staphylococcus aureus, MSSA = methicillin-susceptible Staphylococcus aureus, SCCmec = staphylococcus cassette chromosome mec.
机译:社区相关的耐甲氧西林金黄色葡萄球菌(MRSA)已成为社区和医院感染的重要病原体。这些新兴的MRSA菌株对社区感染金黄色葡萄球菌菌血症成年患者死亡率的影响尚不确定。根据葡萄球菌盒式染色体mec(SCCmec)分子分型的结果,我们定义了社区菌株MRSA(CoSt-MRSA)和医院菌株MRSA(HoSt-MRSA):CoSt-MRSA分离株具有SCCmec IV型或V型基因,以及HoSt-MRSA分离株具有SCCmec I,II或III型基因。我们通过与甲氧西林敏感金黄色葡萄球菌(MSSA)菌血症患者的死亡率进行比较,定量评估了MRSA菌株对CoSt-MRSA或HoSt-MRSA菌血症患者死亡率的影响。我们研究了从2001年1月1日到2007年12月31日的500例MSSA菌血症,111例CoSt-MRSA菌和133例HoSt-MRSA菌血症的观察性队列。 MSSA,CoSt-MRSA和HoSt-MRSA菌血症分别为71%,70%和55%(根据Wilcoxon秩和检验,p = 0.014)。与MSSA菌血症患者相比,HoSt-MRSA菌血症患者在调整所有潜在混杂因素的第一个多变量分析模型中死亡风险增加(危险比[HR]为1.525; 95%置信区间[CI]为1.091) -2.131),在第二个模型中针对除细菌血症的严重程度(HR,1.489; 95%CI,1.071-2.070)以外的所有混杂因素进行调整,并在Charlson合并症得分低的患者中进行分层分析(评分0-2)(HR ,3.093; 95%CI,1.507-6.350)。与MSSA菌血症患者相比,CoSt-MRSA菌血症患者在2个多元分析模型中的死亡率没有显着差异(第一个模型:HR,1.106; 95%CI,0.748-1.637;第二个模型:HR,1.028; 95%CI,0.697-1.516)或分层分析(HR,1.092; 95%CI,0.539-2.214)。总之,使用MSSA作为参考,传统的MRSA医院菌株对菌血症死亡率的影响要高于MRSA社区菌株。缩写:CA-MRSA =社区相关耐甲氧西林金黄色葡萄球菌,CI =置信区间,CoSt-MRSA =耐甲氧西林金黄色葡萄球菌社区菌株,ED =急诊科,HoSt-MRSA =耐甲氧西林金黄色葡萄球菌医院菌株,HR =危险比,MLST =多基因座序列分型,MRSA =耐甲氧西林金黄色葡萄球菌,MSSA =耐甲氧西林金黄色葡萄球菌,SCCmec =葡萄球菌盒式染色体mec。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号